Cancer Care & Body Composition: Southampton University Research

Pioneering Research Links Body Composition to Improved Breast Cancer Treatment

A groundbreaking study,funded by a £1.2 million grant,is exploring how a patient’s body composition could revolutionize breast cancer treatments. The University of Southampton is leading the charge,partnering with eight National Health Service (NHS) trusts to refine treatment strategies based on individual patient profiles.

The research,backed by The World Cancer Research Fund,aims to move beyond traditional methods of gauging patient health.Currently, clinicians rely on basic measurements like weight and height to determine appropriate chemotherapy dosages. however, researchers believe a more nuanced understanding of a patient’s body fat and muscle mass, alongside their exercise habits, is crucial for optimizing care.

did you know? – Chemotherapy dosages are often calculated using body weight, but this method doesn’t account for individual differences in body composition. This can lead to under or overdosing, impacting treatment effectiveness and side effects.

Unlocking Personalized Cancer Care with CANDO

The programme, formally known as CANDO – short for Cancer: Nutrition and Dietary Origins – is already underway.Researchers are analyzing data from 300 patients with early-stage breast cancer currently undergoing chemotherapy. The study will investigate how variations in body composition influence a patient’s response to treatment and the severity of associated side effects.

“There are still many gaps in knowledge of how diet, weight, body composition and physical activity affect the cancer and its treatment,” researchers stated. The team will utilize advanced electronic scans to assess patients’ physical makeup, creating a more comprehensive picture of their overall health.

Pro tip: – Maintaining a healthy lifestyle, including regular exercise and a balanced diet, can positively impact cancer treatment outcomes. Discuss safe exercise routines with your healthcare team.

The potential impact of this research resonates deeply with those who have experienced cancer treatment firsthand. “I understood how rough it can be and how difficult it is to get doses right,” said a breast cancer survivor and patient advocate involved with the project. “This research could allow clinicians in future to reduce the guesswork and give patients with breast cancer an all-round better experience.”

This initiative represents a significant step toward personalized medicine in oncology, promising a future where cancer treatments are tailored to the unique characteristics of each patient. By integrating detailed body composition analysis with existing clinical data,the CANDO program hopes to minimize unneeded side effects and maximize treatment efficacy,ultimately improving outcomes for individuals battling breast cancer.

Reader question: – How might understanding body composition change the way chemotherapy is administered, and what challenges might arise in implementing these changes in a clinical setting?

Here’s the article rewritten as a substantive news report, answering the “Why, Who, What, and How” questions:

Why: Researchers are seeking to improve breast cancer treatment outcomes by moving beyond standard weight-based chemotherapy dosage calculations. They believe a more detailed understanding of a patient’s body composition-specifically fat and muscle mass-along with exercise habits, will lead to more effective and less toxic treatments.

Who: The university of Southampton is leading the £1.2 million research project, funded by The world Cancer Research Fund. They are partnering with eight National Health Service (NHS) trusts. The study involves 300 patients with early-stage breast cancer and includes input from a breast cancer survivor and patient advocate.

what: The study, called CANDO (Cancer: Nutrition and Dietary Origins), is analyzing the relationship between body composition, treatment response, and side effects in early-stage breast cancer patients undergoing chemotherapy. Researchers are using advanced electronic scans to assess patients’ physical makeup.

How: Researchers are collecting data from 300 patients undergoing chemotherapy. They are using advanced scans to measure body fat and muscle mass. This data will be analyzed alongside existing clinical facts to determine how body composition influences treatment effectiveness and side effects. The goal is to develop personalized treatment strategies.

**How did